Helius Shines With Positive PoNS Trial Results

HELIUS MEDICAL TECHNOLOGIES, INC. shares are trading higher after the company announced positive outcomes from its Portable Neuromodulation Stimulator Stroke Registrational Program, supporting a planned FDA submission under breakthrough designation.